Anaphylaxis

Food Allergy

Seasonal Allergy

Allergy

Biosimilars

Arrhythmia

Atherosclerotic Cardiovascular Disease

Dyslipidemia

Heart Failure

Hypertension

Stroke

Structural Heart Disease

Venous Thromboembolism

Cardiology

Acne

Atopic Dermatitis

Chronic Idiopathic Urticaria

Hidradenitis Suppurativa

Plaque Psoriasis

Rosacea

Vitiligo

Dermatology

Hormonal Disorders

Polycystic Ovary Syndrome

Thyroid Disorders

Type 1 Diabetes

Type 2 Diabetes

Endocrinology

FDA News

COVID-19

Influenza

Vaccination

Family Medicine

C Difficile Infection

Gastroesophageal Reflux Disease (GERD)

Inflammatory Bowel Disease

Irritable Bowel Syndrome

Peptic Ulcer

Ulcerative Colitis

Gastroenterology

Alzheimer Disease

Parkinson Disease

Geriatrics

Anemia

Sickle Cell

Hematology

Alpha-1 antitrypsin deficiency

Cholangitis

Hepatitis C

MASH / MASLD

Hepatology

Hospital Medicine

HIV/AIDS

Infectious Disease

Internal Medicine

Chronic Kidney Disease

IgA Nephropathy

Nephrology

Epilepsy

Migraine

Tardive Dyskinesia

Traumatic Brain Injury

Neurology

Obesity Management

Age-Related Macular Degeneration

Diabetic Macular Edema

Geographic Atrophy

Uveitis

Ophthalmology

Acute Pain

Chronic Pain

Multiple Sclerosis

Neuropathic Pain

Pain

Pediatrics

ADHD

Addiction

Bipolar Disorder

Major Depressive Disorder

PTSD

Schizophrenia

Psychiatry

Asthma

COPD

Lung Cancer

Pulmonary Fibrosis

Pulmonology

Amyloidosis

Huntington Disease

Lysosomal Storage Disorders

Vasculitis

RDR Alert®

Fibromyalgia

Gout

Lupus

Osteoarthritis

Osteoporosis

Psoriatic Arthritis

Rheumatoid Arthritis

Spondyloarthritis

Rheumatology

Insomnia

Obstructive Sleep Apnea

Sleep

Plastic surgery

Surgery

Women's Health

News

Media

Podcasts

Shows

State Of Sciences - Presentations

Videos

Webinars

Multimedia Series

CURE Connections®

Insights

Medcast Podcasts

Medcast Videos

News Network

Peer Exchange

Peers & Perspectives

Conferences

Conference Coverage

Conference Listing

Partners

CME/CE

Resources

Digital Supplements

Interactive Tools

Live Events

Press Release

Publications

Advisory Board

Subscribe

 and joined the MJH Life Sciences team in April 2021. He graduated from The College of New Jersey with a degree in Journalism and Professional Writing. He enjoys listening to records, going to concerts, and playing with his cat Squish. You can reach him at 

Articles

Alcohol relapses were detected more frequently after the introduction of phosphatidylethanol in orthotopic liver transplant recipients.

Phosphatidylethanol Aids Detection of Alcohol Relapse Post-Liver Transplant

Tim Smith joined the MJH Life Sciences team as an assistant editor for HCPLive in August 2022. He graduated from UC Berkeley with a degree in political science, working in multimedia journalism as a staff writer prior to joining MJH. In his spare time, he enjoys reading, watching TV, listening to podcasts, and rock climbing. You can contact him at 

Despite the number of individuals with MASLD-related HCC without cirrhosis who report a low FIB-4, current care pathways may not identify such patients for additional assessments.

Study Highlights Limitations of Clinical Pathways for MASLD-Related Hepatocellular Carcinoma

Chelsie Derman is an assistant editor for 

who covers psychiatry, sleep medicine, and geriatrics. She joined MJH Life Sciences in September 2023 after graduating from The College of New Jersey with a bachelor’s degree in journalism and professional writing. In her free time, she enjoys creative writing and reading.

Normothermic machine perfusion in liver transplants improves preservation, reduces early complications, and shows promise in complex cases.

Normothermic Machine Perfusion Shows Promise in High-Acuity Liver Transplants

Victoria Johnson joined the MJH Life Sciences in 2020 and has written for NeurologyLive, CGTLive, and now HCPLive. You can reach her at vjohnson@mjhlifesciences.com

The oral therapy may address limitations including difficulty in application and adverse events with topical therapies. 

Apremilast Improves Outcomes in Scalp Psoriasis 

HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.

About Us

Advertise

Editorial

Contact Us

Do Not Sell My Information

Privacy

Terms & Conditions

HCPLive - Clinical news for connected physicians

Facebook

LinkedIn

Spotlight

The Respiratory Report

Biosimilars Spotlight

DME & nAMD On-Demand Presentation

Clinical

Arterial Disease

Diabetes

Geriatric Medicine

Video Series

Post Conference Perspectives

Dermatologists Drs Tina Bhutani and Scott Boswell and patient Kanya Oul share resources and tools available to cope with generalized pustular psoriasis (GPP).

Tips for Managing Generalized Pustular Psoriasis (GPP)

Coping With and Support for Generalized Pustular Psoriasis (GPP)

In an upcoming Cure Connections program entitled “Barriers to Addressing Sleep Health in Clinical Practice” Dr Paul Doghramji will talk to a patient with insomnia and discuss challenges patients and physicians face when talking about sleep issues and in adequately treating insomnia.

Barriers to Addressing Sleep Health in Clinical Practice

Ted Lain, MD, reviews available support groups, vitiligo education, and other resources for patients with the disease.

Resources for Patients With Vitiligo

Tarasha, a patient with vitiligo, shares her story to help aid dermatologists and other physicians who treat people with the disease, and highlights the importance of transparent communication.

Advice for Physicians Treating Patients With Vitiligo

Cure Connections

Jean-Frederic Colombel, MD, examines considerations for transitioning patients from intravenous to subcutaneous infliximab and evaluates the role of subcutaneous infliximab within the evolving landscape of inflammatory bowel disease treatments. 

Patient Selection and Switching Patients to Subcutaneous Infliximab

A key opinion leader analyzes the clinical remission and endoscopic response data from the LIBERTY CD and LIBERTY UC trials for subcutaneous infliximab-dyyb injection, contrasts it with intravenous infliximab, and evaluates the drug's safety and efficacy profile. 

Efficacy and Safety of Subcutaneous Infliximab  

A key opinion leader discusses off-label treatments for fibromyalgia symptom management and promising ongoing studies, as well as mobile applications that can aid in monitoring and managing fibromyalgia symptoms.


Use of Existing Treatment and Ongoing Research in Treatment of Fibromyalgia

Experts discuss the critical importance of early identification and consistent application of appropriate treatments for fibromyalgia patients to optimize their long-term health outcomes and quality of life.

Importance of Starting on Right Fibromyalgia Treatment Early

Dr. Dennis Marcus discusses how the PDS with ranibizumab fits into the treatment landscape and explores other sustained delivery mechanisms currently in development for neovascular AMD.

Positioning PDS Within the Therapeutic Landscape

Dr Marcus highlights procedure and safety overview for the port delivery system (PDS).

Refilling of PDS and Overall Safety Profile

Lauren Miller, MPAS, PA-C; Jayme M. Heim, MSN FNP-BC, and Kirk Gautier, PA-C, discuss recent advancements in plaque psoriasis treatment, focusing on novel oral systemic therapies like the TYK-2 inhibitor deucravacitinib and its clinical trial data, to inform therapeutic decisions for this systemic disease.

Exploring Oral Systemic Therapies For Plaque Psoriasis: Efficacy, Safety, and Clinical Considerations

Nehad Soloman, MD, FACR; Andrew Sharobeem, DO, FACR, and Sunil Patel, MD, explore the nephrologist's vital role in gout diagnosis, treatment options for gout patients with chronic kidney disease, and strategies for managing refractory gout and its associated challenges.

Moving Beyond the Joint: The Interplay Between Gout and Kidney Disease 

Plaque psoriasis experts explore recent advancements in treatment options, patient experiences, and the potential of novel oral systemic therapies to reduce the burden of this prevalent chronic condition.

Empowering Patients: Defining Moderate Plaque Psoriasis and the Promise of Novel Oral Systemic Treatment

In this segment, Barratt reflects on recent updates in the management of IgA nephropathy, with a focus on updates related to atrasentan. 

How AFFINITY Informs on Potential of Atrasentan, with Jonathan Barratt, MD, PhD